Research advances of SARS-CoV-2 vaccination in malignant cancer patients receiving immune checkpoint inhibitors

BAI Yuanyuan, LI Zhouqiang, QIU Hanbo, YIN Ping, MO Ronglian, HOU Encun

PDF(935 KB)
PDF(935 KB)
Chinese Journal of Infection and Chemotherapy ›› 2023, Vol. 23 ›› Issue (3) : 390-394. DOI: 10.16718/j.1009-7708.2023.03.020
Review

Research advances of SARS-CoV-2 vaccination in malignant cancer patients receiving immune checkpoint inhibitors

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 23(3): 390-394 https://doi.org/10.16718/j.1009-7708.2023.03.020

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(935 KB)

Accesses

Citation

Detail
Sections
Recommended
沪ICP备11042064-1
Copyright © Chinese Journal of Infection and Chemotherapy, All Rights Reserved.
Address：12 Wulumuqi Zhong Road Shanghai, China　
Post Code：200040
Tel: 021-52888148　
　E-mail: cjic@fudan.edu.cn 或 hscjic@fudan.edu.cn
Powered by Beijing Magtech Co. Ltd.

/

〈 〉